CORC  > 四川大学
Primary study of recombinant immunotoxin IL-18-PE38 in treating rheumatoid arthritis
Wu X; Yang C; Zhang L.
刊名Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
2005
卷号Vol.19 No.4页码:306-309
关键词3T3 Cells Animals Arthritis, Rheumatoid/genetics/therapy Cells, Cultured Chondrocytes/cytology/*metabolism Cloning, Molecular Escherichia coli/genetics Exotoxins/genetics Gene Expression Genetic Therapy/methods Genetic Vectors Immunotoxins/genetics/*metabolism Interleukin-18/genetics/*metabolism Mice Microscopy, Fluorescence Plasmids/genetics Recombinant Fusion Proteins/genetics/*metabolism Transfection
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/1910704
专题四川大学
作者单位Department of Biochemistry and Molecular Biology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu Sichuan, 610041, PR China.
推荐引用方式
GB/T 7714
Wu X,Yang C,Zhang L.. Primary study of recombinant immunotoxin IL-18-PE38 in treating rheumatoid arthritis[J]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi,2005,Vol.19 No.4:306-309.
APA Wu X,Yang C,&Zhang L..(2005).Primary study of recombinant immunotoxin IL-18-PE38 in treating rheumatoid arthritis.Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi,Vol.19 No.4,306-309.
MLA Wu X,et al."Primary study of recombinant immunotoxin IL-18-PE38 in treating rheumatoid arthritis".Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi Vol.19 No.4(2005):306-309.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace